To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN)

NCT00518362 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Nephropathy

Interventions

DRUG: TW

Sponsor

Nanjing University School of Medicine